.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Deloitte
Federal Trade Commission
Teva
McKesson
Moodys
McKinsey
Queensland Health
QuintilesIMS
Baxter

Generated: November 19, 2017

DrugPatentWatch Database Preview

Actavis Elizabeth Company Profile

« Back to Dashboard

What is the competitive landscape for ACTAVIS ELIZABETH, and what generic and branded alternatives to ACTAVIS ELIZABETH drugs are available?

ACTAVIS ELIZABETH has one hundred and twenty-three approved drugs.

There are eight tentative approvals on ACTAVIS ELIZABETH drugs.

Summary for Actavis Elizabeth

US Patents:0
Tradenames:82
Ingredients:82
NDAs:123
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Elizabeth
FLUVOXAMINE MALEATE
fluvoxamine maleate
CAPSULE, EXTENDED RELEASE;ORAL091482-002Nov 18, 2013ABRXNoYes► Subscribe► Subscribe► Subscribe
Actavis Elizabeth
LAMOTRIGINE
lamotrigine
TABLET, EXTENDED RELEASE;ORAL200672-003Oct 17, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Elizabeth
FENOFIBRIC ACID
choline fenofibrate
CAPSULE, DELAYED RELEASE;ORAL200920-001Oct 7, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Elizabeth
MIRTAZAPINE
mirtazapine
TABLET;ORAL076241-002Jun 25, 2003DISCNNoNo► Subscribe► Subscribe► Subscribe
Actavis Elizabeth
DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate
TABLET;ORAL206340-001Feb 5, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Elizabeth
PEMOLINE
pemoline
TABLET;ORAL075595-001Feb 28, 2000DISCNNoNo► Subscribe► Subscribe► Subscribe
Actavis Elizabeth
TIZANIDINE HYDROCHLORIDE
tizanidine hydrochloride
TABLET;ORAL076283-002Jul 12, 2002DISCNNoNo► Subscribe► Subscribe► Subscribe
Actavis Elizabeth
HYDROCHLOROTHIAZIDE
hydrochlorothiazide
TABLET;ORAL040707-001Feb 27, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Elizabeth
CLONIDINE HYDROCHLORIDE
clonidine hydrochloride
TABLET, EXTENDED RELEASE;ORAL202792-001May 15, 2015AB2RXNoNo► Subscribe► Subscribe► Subscribe
Actavis Elizabeth
SERTRALINE HYDROCHLORIDE
sertraline hydrochloride
TABLET;ORAL077345-002Feb 6, 2007DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Harvard Business School
Argus Health
Deloitte
Moodys
Mallinckrodt
Chinese Patent Office
Colorcon
Cerilliant
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot